Acyclovir

Product Used For Unknown Indication	24.6%
Herpes Zoster	20.6%
Drug Use For Unknown Indication	9.1%
Prophylaxis	4.9%
Genital Herpes	4.7%
Herpes Simplex	4.7%
Burkitt's Lymphoma	4.2%
Encephalitis Herpes	3.6%
Herpes Virus Infection	2.9%
Antiviral Prophylaxis	2.5%
Pain	2.5%
Encephalitis	2.4%
Meningitis	2.0%
Hiv Infection	1.8%
Varicella	1.8%
Oral Herpes	1.8%
Necrotising Retinitis	1.7%
Hypertension	1.6%
Chemotherapy	1.3%
Immunosuppression	1.1%

Renal Failure Acute	18.4%
Drug Ineffective	12.7%
Vomiting	10.5%
Neurotoxicity	6.8%
Renal Failure	5.7%
Herpes Zoster	4.6%
Nephropathy Toxic	4.1%
Renal Impairment	4.1%
Somnolence	4.1%
Blood Creatinine Increased	3.5%
International Normalised Ratio Increased	3.0%
Pyrexia	3.0%
Tremor	3.0%
Nausea	2.7%
Hallucination	2.4%
Paraesthesia	2.4%
Rash	2.4%
Subdural Haematoma	2.4%
Alopecia	2.2%
Hallucination, Visual	2.2%

Secondary

Product Used For Unknown Indication	22.7%
Drug Use For Unknown Indication	15.1%
Prophylaxis	7.9%
Burkitt's Lymphoma	7.5%
Herpes Zoster	6.3%
Chemotherapy	3.9%
Pain	3.8%
Hiv Infection	3.7%
Antiviral Prophylaxis	3.6%
Infection Prophylaxis	3.6%
Multiple Myeloma	3.1%
Antibiotic Prophylaxis	2.4%
Bone Marrow Conditioning Regimen	2.3%
Pyrexia	2.3%
Herpes Simplex	2.1%
Genital Herpes	2.1%
Immunosuppression	2.1%
Hypertension	2.0%
Antifungal Prophylaxis	1.9%
Prophylaxis Against Graft Versus Host Disease	1.9%

Renal Failure Acute	9.3%
Toxic Epidermal Necrolysis	9.0%
Renal Impairment	8.4%
Renal Failure	7.4%
Pyrexia	6.8%
Herpes Zoster	6.4%
Death	6.1%
Vomiting	5.1%
Ventricular Extrasystoles	4.8%
Venoocclusive Liver Disease	4.5%
Thrombocytopenia	4.2%
Venoocclusive Disease	4.2%
Drug Ineffective	3.9%
Toxic Skin Eruption	3.5%
Neutrophil Pelger-huet Anomaly Present	3.2%
Stevens-johnson Syndrome	2.9%
Febrile Neutropenia	2.6%
Myalgia	2.6%
Neutropenia	2.6%
Rash	2.6%

Concomitant

Product Used For Unknown Indication	26.4%
Drug Use For Unknown Indication	14.0%
Multiple Myeloma	9.8%
Prophylaxis	9.2%
Infection Prophylaxis	4.4%
Prophylaxis Against Graft Versus Host Disease	3.8%
Acute Myeloid Leukaemia	3.3%
Bone Marrow Conditioning Regimen	3.2%
Hiv Infection	3.0%
Pain	2.9%
Antifungal Prophylaxis	2.7%
Diffuse Large B-cell Lymphoma	2.3%
Hypertension	2.2%
Antiviral Prophylaxis	2.2%
Premedication	2.1%
Chronic Lymphocytic Leukaemia	2.0%
Plasma Cell Myeloma	1.9%
Nausea	1.7%
Stem Cell Transplant	1.6%
Depression	1.3%

Vomiting	9.0%
Thrombocytopenia	9.0%
White Blood Cell Count Decreased	8.7%
Pyrexia	8.0%
Pneumonia	7.6%
Death	6.6%
Sepsis	6.0%
Weight Decreased	5.0%
Febrile Neutropenia	4.6%
Weight Increased	3.9%
Neutropenia	3.7%
Pulmonary Embolism	3.5%
Renal Failure Acute	3.4%
Rash	3.2%
Urinary Tract Infection	3.2%
Renal Failure	3.2%
Respiratory Failure	3.0%
Pancytopenia	2.9%
Septic Shock	2.8%
Platelet Count Decreased	2.5%

Interacting

Hepatosplenic Candidiasis	19.7%
Drug Use For Unknown Indication	11.3%
Acute Promyelocytic Leukaemia	8.5%
Infection	8.5%
Herpes Zoster	7.0%
Product Used For Unknown Indication	7.0%
Bacterial Infection	4.2%
Contraception	4.2%
Myocardial Infarction	4.2%
Oral Herpes	4.2%
Diffuse Large B-cell Lymphoma	2.8%
Graft Versus Host Disease	2.8%
Infection Prophylaxis	2.8%
Keratoplasty	2.8%
Lung Transplant	2.8%
Agranulocytosis	1.4%
Anxiety	1.4%
Blood Cholesterol Increased	1.4%
Chronic Obstructive Pulmonary Disease	1.4%
Confusional State	1.4%

Drug Interaction	27.3%
Sinoatrial Block	9.1%
Metrorrhagia	6.8%
Vomiting	6.8%
Arrhythmia	4.5%
Atrioventricular Block Second Degree	4.5%
Drug Level Decreased	4.5%
Myositis	4.5%
Renal Failure	4.5%
Wrong Technique In Drug Usage Process	4.5%
Blood Cholesterol Increased	2.3%
Chills	2.3%
Dry Mouth	2.3%
Herpes Virus Infection	2.3%
Herpes Zoster	2.3%
Leukopenia	2.3%
Muscle Disorder	2.3%
Platelet Function Test Abnormal	2.3%
Retinal Haemorrhage	2.3%
Sinus Bradycardia	2.3%